Clinical efficacy and safety of combination of abraxane and trastuzumab in treatment of recurrent ovarian cancer.Published in:Pakistan Journal of Pharmaceutical Sciences, 2018, v. 31, p. 2831By:Yi Yang;Zhi-shun Lu;Zhu ZengPublication type:Article